
    
      This is a prospective, multi-center, randomized-controlled clinical trial to verify the
      efficacy and safety of DCB made by Acotec Scientific versus RESTORE DEB in treatment of small
      vessel coronary disease. And the primary endpoint is angiographic restenosis at 9 months
      post-procedure.
    
  